Applications of 4-Chloro-5-(p-tolyl)-1H-imidazole-2-carbonitrile in Industrial Manufacturing

4-Chloro-5-(p-tolyl)-1H-imidazole-2-carbonitrile plays a critical role in modern industrial chemistry, primarily serving as an advanced intermediate within several regulated manufacturing chains. Our production capabilities allow for strict batch quality control and support consistent integration into downstream applications across pharmaceutical synthesis and specialty agrochemical development. Below, we highlight genuine and established uses in which this material functions as a key building block under regulated conditions.

1. Pharmaceutical Active Ingredient Synthesis – Anti-infective Agents

This intermediate is frequently incorporated into the synthesis of select anti-infective pharmaceutical actives, especially imidazole-based drugs targeting bacterial and fungal pathogens. Its chemical structure supports further functionalization steps and assists in achieving targeted pharmacological activity, with significant quality oversight through all synthesis stages.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP) as per ICH Q7
• European Pharmacopoeia (Ph. Eur.) monographs on active substances
• United States Pharmacopeia (USP) Chapter <797>
• EDQM Certificate of Suitability (CEP) frameworks where required

Typical usage ratio

• In anti-infective API synthesis, 1.0 - 1.5 molar equivalents relative to the main API scaffold, adjusted based on the selectivity and byproduct profile of each proprietary route.

Downstream process integration

• The intermediate enters at the heterocycle functionalization stage, undergoing subsequent coupling, halogenation, or alkylation following primary imidazole ring synthesis to enable focused molecular assembly.

Final product types

• Broad-spectrum antifungal and antibacterial pharmaceutical actives
• Finished oral and parenteral dosage forms containing imidazole derivatives
• Specialty intermediates for further downstream derivatization

2. Targeted Oncology APIs – Small Molecule Development

As a functionalized imidazole derivative, this raw material is foundational in the assembly of select tyrosine kinase inhibitors and other oncological small molecules. Its cyano and chloro substituents enable high-yield introduction of pharmacophores under controlled reaction sequences, essential for achieving the structural integrity demanded by modern anticancer therapies.

Industry compliance standards

• FDA 21 CFR Part 210/211 (cGMP for finished pharmaceuticals)
• ICH Q3A/B (Impurities controls)
• ISO 9001:2015 for chemical quality management
• Relevant International Conference on Harmonization (ICH) stability guidelines

Typical usage ratio

• 0.8 – 1.2 molar equivalents, varying according to the target molecule and the required protection/deprotection strategy in the assembly of the API core.

Downstream process integration

• Introduced immediately after key arylation steps, offering selective electrophilic substitution to yield final API frameworks prior to salt formation and formulation stages.

Final product types

• Imidazole-based kinase inhibitors for targeted cancer therapy
• Active pharmaceutical ingredients for solid and injectable oncology products
• Clinical batch samples for use in regulatory drug trials

3. Agrochemical Synthesis – Fungicide and Pesticide Intermediates

Chemical manufacturers leverage this imidazole compound as a strategic intermediate in producing systemic fungicides and crop protection agents. Its utility lies in its reactivity within multi-step synthesis processes, granting access to next-generation actives that demand trace-level impurity monitoring and documented batch traceability for agricultural regulatory approval.

Industry compliance standards

• FAO/WHO Specification for Plant Protection Products
• REACH (EC No 1907/2006) chemical registration and tracking
• ISO 17025 laboratory quality accreditation for residue testing
• National agrochemical active registrations (e.g., US EPA, EU Regulation (EC) No 1107/2009)

Typical usage ratio

• Ranges from 3 – 7% w/w in active ingredient synthesis steps, with adjustments specific to targeted product purity and stepwise conversion rates.

Downstream process integration

• The compound incorporates into the heterocycle assembly early in the synthesis of the fungicidal active, preceding halogen substitution, followed by further extension, isolation, and purification to meet final product standards.

Final product types

• Imidazole-derived systemic fungicide technical concentrates
• Emulsifiable concentrate (EC) and water dispersible granule (WG) formulations for crop protection
• Seed treatment active ingredient blends

4. Fine Chemical Intermediates – Custom Synthesis for Research

Contract research organizations and specialty chemical labs select this building block for complex organic synthesis, specifically where functionalized imidazole motifs are required in preclinical compound screening. Its defined impurity profile and stable shipment format add value at pilot and scale-up stages where strict documentation is mandatory.

Industry compliance standards

• ISO 9001:2015 Quality management for production and QC documentation
• OECD GLP (Good Laboratory Practice) for compound traceability
• IUPAC chemical nomenclature and labeling standards
• Material compatibility with institutional hazard communication programs (GHS/CLP)

Typical usage ratio

• Utilized in custom synthesis, 0.5 – 2.5 mmol scale, according to downstream target library design and yield optimization requirements.

Downstream process integration

• Added at initial heteroaromatic coupling or cyclization stages within multi-component reaction protocols, followed by chromatographic purification and analytical characterization for structural confirmation.

Final product types

• Reference standards for analytical methods
• Specialty screening libraries for early-phase drug discovery
• Functionalized imidazole test compounds for reaction pathway validation